Patient Characteristics and Practice Variation Associated With New Community Prescription of Benzodiazepine and z‐Drug Hypnotics After Critical Illness: A Retrospective Cohort Study Using the <scp>UK</scp> Clinical Practice Research Datalink
One in twenty critical illness survivors receive a new community benzodiazepine or z-drug prescription. Further research is needed to understand where in the patient care pathway initiation occurs and the risk of adverse events in survivors of recent critical illness.
Authors
- Richard S Bourne (ORCID: https://orcid.org/0000-0003-0893-525X)
- Christopher T. Rentsch (ORCID: https://orcid.org/0000-0002-1408-7907)
- Elizabeth T. Mansi (ORCID: https://orcid.org/0000-0002-9625-3752)
- Bruce Guthrie (ORCID: https://orcid.org/0000-0003-4191-4880)
- Nazir Lone (ORCID: https://orcid.org/0000-0003-2707-2779)
Institutions
- Manchester Academic Health Science Centre (GB)
- University of Manchester (GB)
- Yale University (US)
- London School of Hygiene & Tropical Medicine (GB)
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1002/pds.70056
- Citations
- 2
- Primary Topic
- Intensive Care Unit Cognitive Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.84